4-methylnonan-5-ol

CAS No. 154170-44-2

4-methylnonan-5-ol( —— )

Catalog No. M37396 CAS No. 154170-44-2

4-methylnonan-5-ol is a pheromone of red palm weevils and can be used to capture red palm weevils and reduce their harm to agriculture.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 30 In Stock
25MG 46 In Stock
50MG 62 In Stock
100MG 88 In Stock
200MG 128 In Stock
500MG 213 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-methylnonan-5-ol
  • Note
    Research use only, not for human use.
  • Brief Description
    4-methylnonan-5-ol is a pheromone of red palm weevils and can be used to capture red palm weevils and reduce their harm to agriculture.
  • Description
    4-methylnonan-5-ol is a pheromone of red palm weevils and can be used to capture red palm weevils and reduce their harm to agriculture.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    154170-44-2
  • Formula Weight
    158.28
  • Molecular Formula
    C10H22O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCC(O)C(C)CCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Oxacillin sodium

    Oxacillin sodium salt is a narrow-spectrum β-lactam antibiotic of the penicillin class.

  • LS-102

    LS-102 is a selective E3 ubiquitin ligase synoviolin (Syvn1) inhibitor. LS-102 inhibits the autoubiquitination of synoviolin with an IC50 of 35 μM. LS-102 has the potential for rheumatoid arthritis treatment.

  • PF-00835231

    PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively.PF-00835231 is the active compound of the first anti-3CLpro regimen in clinical trials.